Sofinnova Capital VII FCPR, 10% Owner at Shockwave Medical, Inc. (SWAV), sold 571,246 shares at $55.04 ($31.7M) on 2020-08-17, disclosed to the SEC on 2020-08-20.
Scheduled sale ($31.7M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.04 | 61,823 | $3.4M | 10.7% |
| 2 | $55.04 | 61,823 | $3.4M | 10.7% |
| 3 | $55.08 | 133,922 | $7.4M | 23.2% |
| 4 | $55.08 | 133,922 | $7.4M | 23.2% |
| 5 | $55.37 | 18,720 | $1.0M | 3.3% |
| 6 | $55.37 | 18,720 |
| $1.0M |
| 3.3% |
| 7 | $56.79 | 40,720 | $2.3M | 7.3% |
| 8 | $56.79 | 40,720 | $2.3M | 7.3% |
| 9 | $57.08 | 30,438 | $1.7M | 5.5% |
| 10 | $57.08 | 30,438 | $1.7M | 5.5% |
| Total | $55.55 avg | 571,246 | $31.7M | 100% |
| Filing → |
| SWAV | SELL | 2020-08-10 | $7.3M | — | Filing → |
| SWAV | SELL | 2020-08-05 | $23.0M | — | Filing → |
| SWAV | SELL | 2020-06-11 | $16.0M | — | Filing → |